Skip to content

Sarasin & Partners LLP: CME position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Sarasin & Partners LLP on CME, newest first. How the timeline and the estimate are built.

Sarasin & Partners LLP held 1,314,268 CME shares at 2026-06-30 per its 13F-HR filed 2026-07-07.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,314,268 shares
    Change vs previous 13F +383,581 shares

    3.4% of the 13F portfolio, value $290,229,815.

    13F-HR 0001510481-26-000003 filed by Sarasin & Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 930,687 shares
    Change vs previous 13F -162,250 shares

    3.35% of the 13F portfolio, value $274,878,420.

    13F-HR 0001510481-26-000002 filed by Sarasin & Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,092,937 shares
    Change vs previous 13F -32,308 shares

    3.1% of the 13F portfolio, value $298,459,238.

    13F-HR 0001510481-26-000001 filed by Sarasin & Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,125,245 shares
    Change vs previous 13F +110,373 shares

    3.01% of the 13F portfolio, value $306,336,709.

    13F-HR 0001085146-25-005903 filed by Sarasin & Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,014,872 shares
    Change vs previous 13F -157,718 shares

    2.78% of the 13F portfolio, value $279,719,033.

    13F-HR 0001085146-25-003615 filed by Sarasin & Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F/A 1,172,590 shares
    Change vs previous 13F -563,121 shares

    3.37% of the 13F portfolio, value $311,076,405.

    13F-HR/A 0001085146-25-002097 filed by Sarasin & Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,735,711 shares
    Change vs previous 13F -19,904 shares

    4.45% of the 13F portfolio, value $403,084,162.

    13F-HR 0001085146-25-000270 filed by Sarasin & Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 1,755,615 shares
    Change vs previous 13F not available

    3.65% of the 13F portfolio, value $387,376,470.

    13F-HR 0001085146-24-004737 filed by Sarasin & Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).